Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway

1 Jan 2018

Abstract excerpt

Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options. Activation of the AKT/mTOR cascade is one of the most frequent events along hepatocarcinogenesis. mTOR is a serine/threonine kinase and presents in two distinct complexes: mTORC1 and mTORC2. While mTORC1 has been extensively studied in HCC, the functional contribution of mTORC2 during hepatocarcinogenesis has not been well...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Liver physiology and pathology
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29303510
DOI: 10.1038/emm.2017.158

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathwayPMID 29303510Read ↗

CRISPR-mediated direct mutation of cancer genes in the mouse liver.Semantic proximity Read ↗

Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted TherapiesSemantic proximity Read ↗

Rap_GAP Domain of TSC2 Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular Carcinoma.Semantic proximity Read ↗

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinomaSemantic proximity Read ↗

Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade.Semantic proximity Read ↗

Cooperation between liver-specific mutations of pten and tp53 genetically induces hepatocarcinogenesis in zebrafish.Semantic proximity Read ↗

Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in MiceSemantic proximity Read ↗

Genetically Engineered Mouse Models for Liver CancerSemantic proximity Read ↗

Effect of stability of PTEN on hepatocellular carcinoma.Semantic proximity Read ↗

CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.Semantic proximity Read ↗

Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis.Semantic proximity Read ↗

Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.